Cargando…

Synthesis and Characterization of Gefitinib and Paclitaxel Mono and Dual Drug-Loaded Blood Cockle Shells (Anadara granosa)-Derived Aragonite CaCO(3) Nanoparticles

Calcium carbonate has slowly paved its way into the field of nanomaterial research due to its inherent properties: biocompatibility, pH-sensitivity, and slow biodegradability. In our efforts to synthesize calcium carbonate nanoparticles (CSCaCO(3)NP) from blood cockle shells (Anadara granosa), we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Chemmalar, S., Intan-Shameha, Abdul Razak, Abdullah, Che Azurahanim Che, Ab Razak, Nor Asma, Yusof, Loqman Mohamad, Ajat, Mokrish, Gowthaman, N. S. K., Bakar, Md Zuki Abu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398682/
https://www.ncbi.nlm.nih.gov/pubmed/34443820
http://dx.doi.org/10.3390/nano11081988
Descripción
Sumario:Calcium carbonate has slowly paved its way into the field of nanomaterial research due to its inherent properties: biocompatibility, pH-sensitivity, and slow biodegradability. In our efforts to synthesize calcium carbonate nanoparticles (CSCaCO(3)NP) from blood cockle shells (Anadara granosa), we developed a simple method to synthesize CSCaCO(3)NP, and loaded them with gefitinib (GEF) and paclitaxel (PTXL) to produce mono drug-loaded GEF-CSCaCO(3)NP, PTXL-CSCaCO(3)NP, and dual drug-loaded GEF-PTXL-CSCaCO(3)NP without usage of toxic chemicals. Fourier-transform infrared spectroscopy (FTIR) results reveal that the drugs are bound to CSCaCO(3)NP. Scanning electron microscopy studies reveal that the CSCaCO(3)NP, GEF-CSCaCO(3)NP, PTXL-CSCaCO(3)NP, and GEF-PTXL-CSCaCO(3)NP are almost spherical nanoparticles, with a diameter of 63.9 ± 22.3, 83.9 ± 28.2, 78.2 ± 26.4, and 87.2 ± 26.7 (nm), respectively. Dynamic light scattering (DLS) and N(2) adsorption-desorption experiments revealed that the synthesized nanoparticles are negatively charged and mesoporous, with surface areas ranging from ~8 to 10 (m(2)/g). Powder X-ray diffraction (PXRD) confirms that the synthesized nanoparticles are aragonite. The CSCaCO(3)NP show excellent alkalinization property in plasma simulating conditions and greater solubility in a moderately acidic pH medium. The release of drugs from the nanoparticles showed zero order kinetics with a slow and sustained release. Therefore, the physico-chemical characteristics and in vitro findings suggest that the drug loaded CSCaCO(3)NP represent a promising drug delivery system to deliver GEF and PTXL against breast cancer.